PL3174852T3 - Arylohydrazydy zawierające ugrupowanie 2-pirydonu jako selektywne środki przeciwbakteryjne - Google Patents

Arylohydrazydy zawierające ugrupowanie 2-pirydonu jako selektywne środki przeciwbakteryjne

Info

Publication number
PL3174852T3
PL3174852T3 PL15750274T PL15750274T PL3174852T3 PL 3174852 T3 PL3174852 T3 PL 3174852T3 PL 15750274 T PL15750274 T PL 15750274T PL 15750274 T PL15750274 T PL 15750274T PL 3174852 T3 PL3174852 T3 PL 3174852T3
Authority
PL
Poland
Prior art keywords
antibacterial agents
selective antibacterial
arylhydrazides
pyridone moiety
pyridone
Prior art date
Application number
PL15750274T
Other languages
English (en)
Inventor
Domingo Gargallo Viola
Albert Palomer Benet
Original Assignee
ABAC Therapeutics, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ABAC Therapeutics, S.L. filed Critical ABAC Therapeutics, S.L.
Publication of PL3174852T3 publication Critical patent/PL3174852T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86Hydrazides; Thio or imino analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86Hydrazides; Thio or imino analogues thereof
    • C07D213/87Hydrazides; Thio or imino analogues thereof in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL15750274T 2014-07-30 2015-07-29 Arylohydrazydy zawierające ugrupowanie 2-pirydonu jako selektywne środki przeciwbakteryjne PL3174852T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14179089 2014-07-30
PCT/EP2015/067345 WO2016016291A1 (en) 2014-07-30 2015-07-29 Arylhydrazides containing a 2-pyridone moiety as selective antibacterial agents
EP15750274.1A EP3174852B1 (en) 2014-07-30 2015-07-29 Arylhydrazides containing a 2-pyridone moiety as selective antibacterial agents

Publications (1)

Publication Number Publication Date
PL3174852T3 true PL3174852T3 (pl) 2018-11-30

Family

ID=51260651

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15750274T PL3174852T3 (pl) 2014-07-30 2015-07-29 Arylohydrazydy zawierające ugrupowanie 2-pirydonu jako selektywne środki przeciwbakteryjne

Country Status (18)

Country Link
US (1) US9840467B2 (pl)
EP (1) EP3174852B1 (pl)
JP (1) JP2017523197A (pl)
KR (1) KR20170038822A (pl)
CN (1) CN106660962A (pl)
AU (1) AU2015295380A1 (pl)
BR (1) BR112017001803A2 (pl)
CA (1) CA2955559A1 (pl)
CL (1) CL2017000231A1 (pl)
DK (1) DK3174852T3 (pl)
ES (1) ES2687826T3 (pl)
MX (1) MX2017001280A (pl)
PE (1) PE20170430A1 (pl)
PH (1) PH12017500057A1 (pl)
PL (1) PL3174852T3 (pl)
PT (1) PT3174852T (pl)
RU (1) RU2017101154A (pl)
WO (1) WO2016016291A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016347456B2 (en) 2015-10-27 2018-12-13 F. Hoffmann-La Roche Ag Peptide macrocycles against acinetobacter baumannii
ES2651943B2 (es) 2016-07-29 2018-08-14 ABAC Therapeutics, S.L. Agentes antibacterianos de 2-pirrolidin fenilihidrazidas
US11505573B2 (en) 2018-03-28 2022-11-22 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii
US11819532B2 (en) 2018-04-23 2023-11-21 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii
WO2020169683A1 (en) * 2019-02-19 2020-08-27 Yncrea Hauts De France Hydrazonopyrrolidine derivatives for use in preventing and/or treating disorders associated to acinetobacter baumannii
WO2020169682A1 (en) * 2019-02-19 2020-08-27 Yncrea Hauts De France Hydrazide derivatives and their specific use as antibacterial agents by controlling acinetobacter baumannii bacterium

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0399058A (ja) * 1989-09-09 1991-04-24 Kaken Pharmaceut Co Ltd 複素5員環化合物
OA12771A (en) * 2002-02-14 2006-07-04 Pharmacia Corp Substituted pyridinones as modulators of P38 map kinase.
SE0203348D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab Novel compounds
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
AU2005211349A1 (en) * 2004-01-30 2005-08-18 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. N-benzyl-3,4-dihyroxypyridine-2-carboxamide and N-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as HIV integrase inhibitors
WO2012051708A1 (en) * 2010-10-21 2012-04-26 The University Of British Columbia Anti-bacterial pyruvate kinase modulator compounds, compositions, uses, and methods
EP2859007B1 (en) * 2013-07-14 2019-04-17 Olle Svenssons Partiaffär AB Alkaloid compositions from ribes species to treat conditions associated with mitochondrial function or inhibition of pde4, pde5 and ikk-beta
KR102076820B1 (ko) * 2013-10-21 2020-02-13 주식회사 대웅테라퓨틱스 신규한 항진균성 옥소다이하이드로피리딘카보하이드라자이드 유도체

Also Published As

Publication number Publication date
CN106660962A (zh) 2017-05-10
PT3174852T (pt) 2018-10-23
EP3174852B1 (en) 2018-07-18
AU2015295380A1 (en) 2017-02-02
WO2016016291A1 (en) 2016-02-04
RU2017101154A (ru) 2018-08-30
ES2687826T3 (es) 2018-10-29
CL2017000231A1 (es) 2017-07-28
CA2955559A1 (en) 2016-02-04
RU2017101154A3 (pl) 2019-01-30
MX2017001280A (es) 2017-06-20
JP2017523197A (ja) 2017-08-17
DK3174852T3 (en) 2018-09-10
KR20170038822A (ko) 2017-04-07
EP3174852A1 (en) 2017-06-07
PE20170430A1 (es) 2017-04-13
US9840467B2 (en) 2017-12-12
US20170217887A1 (en) 2017-08-03
BR112017001803A2 (pt) 2018-02-14
PH12017500057A1 (en) 2017-05-15

Similar Documents

Publication Publication Date Title
SG11201702827VA (en) Immunoregulatory agents
ZA201605816B (en) Compound roll
ZA201708720B (en) Reel
HUP1400264A2 (en) Dasatinib salts
PT3174852T (pt) Aril-hidrazidas contendo uma unidade 2-piridona como agentes antibacterianos seletivos
ZA201606715B (en) Antibacterial compounds
PL3548235T3 (pl) Maszyna rozcinająca
GB201402267D0 (en) Antibacterial agents
PT3209224T (pt) Tira de blister
ZA201701783B (en) Pyridine compounds
HUP1600030A2 (en) Baricitinib salts
PL3175044T3 (pl) Modułowe przeciwuderzeniowe urządzenie osłaniające
GB2557959B (en) A reel
GB2544451B (en) A cutting device
ZA201607393B (en) Absorbent product comprising a microbe-inhibiting composition
SG11201700081VA (en) Knitting spool
GB201503738D0 (en) A cutting device
GB201619872D0 (en) Sachet cutter
ZA201504831B (en) Locating a product
GB201506882D0 (en) A cutting device
GB201417939D0 (en) Antibacterial compounds
GB201417941D0 (en) Antibacterial compounds
GB201411174D0 (en) Tidy reel
GB201414205D0 (en) Antibacterial compounds
GB201408594D0 (en) New salts